Vimarsana
Biggest News Aggregation in the World

Page 7 - Physician Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Physician Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Physician Lab Today - Breaking & Trending Today

Global Sepsis Diagnostics Markets Report 2021: Rapid Diagnositics and the Genomics Revolution are Merging to Create New Diagnostic Opportunities - Vimarsana News

Global Sepsis Diagnostics Markets Report 2021: Rapid Diagnositics and the Genomics Revolution are Merging to Create New Diagnostic Opportunities

5.3.3 Diagnostics Moves Out of the Lab 5.3.4 Biomarkers and Algorithms 5.3.6 Genome Role and Big Data 5.3.7 The Next Five Years 6 Sepsis Diagnostics - Recent Developments 6.1 Recent Developments - Importance and How to Use This Section 6.1.1 Importance of These Developments 6.1.2 How to Use This Section 6.2 Study Establishes Cytovale IntelliSep Test for Rapid Diagnosis of Sepsis 6.3 Baebies Awarded $11.6M to Develop Diagnostic Platform to ID Sepsis 6.4 Personalized Medicine in Sepsis 6.5 Point-of-care Device can Diagnose Sepsis in 30 Minutes 6.6 SpeeDx Developing Respiratory Virus Host-Respon...

Global PCR Markets Forecasts Report 2021-2025: Covid-19 Drives PCR Market Expansion - New Multiplex Markets See Accelerated Development Outlook - Vimarsana News

Global PCR Markets Forecasts Report 2021-2025: Covid-19 Drives PCR Market Expansion - New Multiplex Markets See Accelerated Development Outlook

4.3.3 Diagnostics Moves Out of the Hospital 4.3.4 Disruption Looms 5. PCR Recent Developments 5.1.1 Importance of These Developments Scope Fluidics Secures €6.2M Supporting Rapid MDx Quidel Expects SARS-CoV-2 Testing Demand to Continue 'Through 2022, and Beyond' Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition HelixBind Receives $3M NIH Grant to Expand Bloodstream Infection Dx Platform Israel's Nucleix Targeting US Market With Noninvasi...

Global Molecular Diagnostics for Cancer Markets Report 2021-2025: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs; COVID-19 Causes Resources Shift - Vimarsana News

Global Molecular Diagnostics for Cancer Markets Report 2021-2025: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs; COVID-19 Causes Resources Shift

7 Molecular Diagnostics Recent Developments 7.1 Recent Developments - Importance and How to Use This Section 7.1.1 Importance of These Developments 7.1.2 How to Use This Section 7.2 Nucleix to Invest in Early-Stage Lung Cancer Dx 7.3 Invitae to Acquire Genosity for $200M 7.4 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test 7.5 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience 7.6 Natera Revenues Grow 35 Percent 7.7 AnchorDx Closes $40M Financing Round 7.8 Exact Sciences Strategy for End-to-End Cancer Testing 7.9 Genomics England: Whole Genome Sequenci...

Global Cancer Molecular Diagnostics Markets 2021-2025 - New Diagnostics Create New Markets - Vimarsana News

Global Cancer Molecular Diagnostics Markets 2021-2025 - New Diagnostics Create New Markets

A market with fundamental growth factors is impacted by the COVID-19 Pandemic. Molecular Diagnostics for Cancer is positioned to directly benefit from the explosion in genomics knowledge but shifting resources to deal with the COVID emergency may interrupt growth. Learn all about it in this new report. the publisher includes a special segment, Cancer Companion Diagnostics, a new segment of the market that is reshaping the industry. And now over 130 companies are profiled. A range of dynamic trends are pushing market growth and company valuations. Working against this dynamic market are the f...

Global Liquid Biopsy Markets Report 2021-2025 - Liquid Biopsy Progress Delayed by COVID Pandemic but Huge Cancer Screening Opportunity Still Looms - Vimarsana News

Global Liquid Biopsy Markets Report 2021-2025 - Liquid Biopsy Progress Delayed by COVID Pandemic but Huge Cancer Screening Opportunity Still Looms

3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development 3.4.2 Impact of NGS on pricing 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay 4. Liquid Biopsy Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Liquid Biopsy NGS Panels - Diverse Test Claims CMS Colon Cancer Screening Memo Bodes Well for Assays Natera Liquid Biopsy Test Coverage to Expand Freenome Closes Financing to...